178 related articles for article (PubMed ID: 23242280)
1. Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases.
Tanji K; Maruyama A; Odagiri S; Mori F; Itoh K; Kakita A; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2013 Jan; 72(1):18-28. PubMed ID: 23242280
[TBL] [Abstract][Full Text] [Related]
2. Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in α-synucleinopathy.
Odagiri S; Tanji K; Mori F; Kakita A; Takahashi H; Wakabayashi K
Acta Neuropathol; 2012 Aug; 124(2):173-86. PubMed ID: 22484440
[TBL] [Abstract][Full Text] [Related]
3. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC).
Miklossy J; Steele JC; Yu S; McCall S; Sandberg G; McGeer EG; McGeer PL
Acta Neuropathol; 2008 Dec; 116(6):625-37. PubMed ID: 18843496
[TBL] [Abstract][Full Text] [Related]
4. DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders.
Kumaran R; Kingsbury A; Coulter I; Lashley T; Williams D; de Silva R; Mann D; Revesz T; Lees A; Bandopadhyay R
Neurobiol Dis; 2007 Oct; 28(1):122-32. PubMed ID: 17719794
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies.
Kawamoto Y; Kobayashi Y; Suzuki Y; Inoue H; Tomimoto H; Akiguchi I; Budka H; Martins LM; Downward J; Takahashi R
J Neuropathol Exp Neurol; 2008 Oct; 67(10):984-93. PubMed ID: 18800009
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders.
Mori F; Nishie M; Piao YS; Kito K; Kamitani T; Takahashi H; Wakabayashi K
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):53-61. PubMed ID: 15634231
[TBL] [Abstract][Full Text] [Related]
7. Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy.
Tanikawa S; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
Neurosci Lett; 2012 Oct; 527(1):16-21. PubMed ID: 22947304
[TBL] [Abstract][Full Text] [Related]
8. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
[TBL] [Abstract][Full Text] [Related]
9. Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases.
Schwab C; DeMaggio AJ; Ghoshal N; Binder LI; Kuret J; McGeer PL
Neurobiol Aging; 2000; 21(4):503-10. PubMed ID: 10924763
[TBL] [Abstract][Full Text] [Related]
10. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
[TBL] [Abstract][Full Text] [Related]
11. RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1.
Bakkar N; Kousari A; Kovalik T; Li Y; Bowser R
Mol Cell Biol; 2015 Jul; 35(14):2385-99. PubMed ID: 25939382
[TBL] [Abstract][Full Text] [Related]
12. ALS-associated protein FIG4 is localized in Pick and Lewy bodies, and also neuronal nuclear inclusions, in polyglutamine and intranuclear inclusion body diseases.
Kon T; Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2014 Feb; 34(1):19-26. PubMed ID: 23888880
[TBL] [Abstract][Full Text] [Related]
13. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
Stępkowski TM; Kruszewski MK
Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
[TBL] [Abstract][Full Text] [Related]
14. Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice.
Mimoto T; Miyazaki K; Morimoto N; Kurata T; Satoh K; Ikeda Y; Abe K
Brain Res; 2012 Mar; 1446():109-18. PubMed ID: 22353756
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy.
Chiba Y; Takei S; Kawamura N; Kawaguchi Y; Sasaki K; Hasegawa-Ishii S; Furukawa A; Hosokawa M; Shimada A
Neuropathol Appl Neurobiol; 2012 Oct; 38(6):559-71. PubMed ID: 22013984
[TBL] [Abstract][Full Text] [Related]
16. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
[TBL] [Abstract][Full Text] [Related]
17. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia.
Zhang H; Tan CF; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
Acta Neuropathol; 2008 Jan; 115(1):115-22. PubMed ID: 17786458
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions.
Miki Y; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2011 Dec; 31(6):561-8. PubMed ID: 21284752
[TBL] [Abstract][Full Text] [Related]
19. Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies.
Higashi S; Moore DJ; Minegishi M; Kasanuki K; Fujishiro H; Kabuta T; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H; Wada K; Iseki E
J Neuropathol Exp Neurol; 2011 Apr; 70(4):264-80. PubMed ID: 21412173
[TBL] [Abstract][Full Text] [Related]
20. Expression of Nrf2 in neurodegenerative diseases.
Ramsey CP; Glass CA; Montgomery MB; Lindl KA; Ritson GP; Chia LA; Hamilton RL; Chu CT; Jordan-Sciutto KL
J Neuropathol Exp Neurol; 2007 Jan; 66(1):75-85. PubMed ID: 17204939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
